The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((R)-(2-Chlorophenyl)(7-(4-((1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl)-2-pyridinyl)-1-benzothiophen-2-yl)methyl)cyclopropanesulfonamide ID: ALA3747490
PubChem CID: 72550209
Max Phase: Preclinical
Molecular Formula: C26H22ClF3N2O3S2
Molecular Weight: 567.05
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@](O)(c1ccnc(-c2cccc3cc([C@H](NS(=O)(=O)C4CC4)c4ccccc4Cl)sc23)c1)C(F)(F)F
Standard InChI: InChI=1S/C26H22ClF3N2O3S2/c1-25(33,26(28,29)30)16-11-12-31-21(14-16)19-7-4-5-15-13-22(36-24(15)19)23(18-6-2-3-8-20(18)27)32-37(34,35)17-9-10-17/h2-8,11-14,17,23,32-33H,9-10H2,1H3/t23-,25+/m1/s1
Standard InChI Key: MBAGUBQPZLMGBR-NOZRDPDXSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
6.9420 -0.1864 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3556 -1.2334 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.7423 -0.2019 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6300 5.4281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5886 6.0244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5472 6.6206 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.6206 8.1293 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.5837 7.5252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5423 8.1215 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.8549 -1.2525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0872 0.0371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9982 3.0140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2977 3.7689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2918 5.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0102 6.0138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3063 5.2587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3004 3.7588 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8205 1.3465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3205 1.3681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0518 2.6778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2832 3.9659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7834 3.9444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0521 2.6348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9354 0.3376 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.5792 8.7252 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1233 -2.5230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0966 -3.9442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3855 -3.1769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 1 0
5 6 1 1
8 7 1 0
9 8 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
12 16 1 0
17 18 1 0
18 19 2 0
19 20 1 0
14 20 2 0
15 17 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
21 26 2 0
17 21 1 0
11 12 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
27 32 2 0
28 33 1 0
11 27 1 0
11 10 1 1
23 5 1 0
5 8 1 0
8 34 1 0
10 2 1 0
2 35 1 0
36 35 1 0
37 36 1 0
35 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 567.05Molecular Weight (Monoisotopic): 566.0712AlogP: 6.56#Rotatable Bonds: 7Polar Surface Area: 79.29Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.35CX Basic pKa: 3.88CX LogP: 5.92CX LogD: 5.92Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.27Np Likeness Score: -0.89
References 1. Pennington LD, Bartberger MD, Croghan MD, Andrews KL, Ashton KS, Bourbeau MP, Chen J, Chmait S, Cupples R, Fotsch C, Helmering J, Hong FT, Hungate RW, Jordan SR, Kong K, Liu L, Michelsen K, Moyer C, Nishimura N, Norman MH, Reichelt A, Siegmund AC, Sivits G, Tadesse S, Tegley CM, Van G, Yang KC, Yao G, Zhang J, Lloyd DJ, Hale C, St Jean DJ.. (2015) Discovery and Structure-Guided Optimization of Diarylmethanesulfonamide Disrupters of Glucokinase-Glucokinase Regulatory Protein (GK-GKRP) Binding: Strategic Use of a N → S (nN → σ*S-X) Interaction for Conformational Constraint., 58 (24): [PMID:26551034 ] [10.1021/acs.jmedchem.5b01367 ]